Evan Anderson, CEO & Board Member, Luma Therapeutics
Evan Anderson, CEO and Board Member of Luma Therapeutics, has 17 years of experience in early stage product and market development. He completed the Stanford Biodesign Fellowship in 2004 and was first manager of R&D and then distribution sales at Spiracur (acquired by Acelity).
From the Luma Therapeutics website:
We are a medical device company developing light therapies for the 40 million people in the US with inflammatory skin disorders. Luma Therapeutics was born when our CEO Evan Anderson found that he had psoriasis and discovered a way to treat himself effectively. He knew then that he wanted to develop similar treatments for the millions of other people suffering from skin disorders.
We work hard every day to help people get clear skin with easy to use, affordable therapies.
Our goal is to develop an at home treatment that will put psoriasis in remission for an extended period of time after only a few weeks of therapy.
Ravyn Miller: Speedbumps Accelerate Access
Alison Darcy: Robot Empathy
Jason Bellet: Advisers and Adopters
Tomas Chamorro-Premuzic: Confidence and Competence
Daniel Kraft: Harnessing Digital Exhaust
Ali Tamaseb: What Makes a Super Founder?
The Perfect Storm: Jon Norris on Investing During COVID--19
Seeing Yourself Clearly: Erika Andersen on Leadership
Lusi Chien: Listening is the First Step
Harry Kraemer: The Fundamentals of Leadership
Kate Rosenbluth: Treating Essential Tremor
Claudia Williams: Unlocking Health Data
Zeeshan Syed: Machine Intelligence in Healthcare Systems
Oren Levy: The Pursuit of a Good Challenge
Dr. Katherine Scangos: Exploring Neural Circuits
Connor Landgraf: Beyond the Stethoscope
Julia Hu: Creating an AI Nurse
Sharon Vosmek: Inclusion in Venture Capital
SC Moatti: What Makes a Great Product?
Maria Sainz: Becoming a Better Leader & Team Manager
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money